Amid a shortage of amoxicillin and penicillin — the two main antibiotics for strep infections, which rose in early 2023 — Pfizer said it has “limited supply and [an] impending stock out situation” for some of its penicillin prefilled syringe products.
Read the full post on Becker's Hospital Review - Healthcare News